Serotonin-1A receptor binding is positively associated with gray matter volume - A multimodal neuroimaging study combining PET and structural MRI

NeuroImage

Volumn 63, Issue 3, 2012, Pages 1091-1098

  Kraus, Christoph ^a   Hahn, Andreas ^a   Savli, Markus ^a   Kranz, Georg S ^a   Baldinger, Pia ^a   Höflich, Anna ^a   Spindelegger, Christoph ^a   Ungersboeck, Johanna ^a   Haeusler, Daniela ^a   Mitterhauser, Markus ^a   Windischberger, Christian ^b   Wadsak, Wolfgang ^a   Kasper, Siegfried ^a   Lanzenberger, Rupert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

Author keywords

5 HT1A receptor; Positron emission tomography; Structural magnetic resonance imaging

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE CARBONYL C 11; RADIOLIGAND; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANATOMICAL VARIATION; ARTICLE; BRAIN SIZE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOREBRAIN; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; MALE; MESENCEPHALON; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SEX DIFFERENCE; TEMPORAL CORTEX;

ADULT; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT1A; YOUNG ADULT;

EID: 84866122653     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.07.035     Document Type: Article

References (58)

1. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry 2009, 66:627-635.
2. Amargós-Bosch M., Bortolozzi A., Puig M.V., Serrats J., Adell A., Celada P., Toth M., Mengod G., Artigas F. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 2004, 14:281-299.
3. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
4. Ashburner J., Friston K.J. Computing average shaped tissue probability templates. NeuroImage 2009, 45:333-341.
5. Azmitia E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 2001, 56:413-424.
6. Benninghoff J., Gritti A., Rizzi M., Lamorte G., Schloesser R.J., Schmitt A., Robel S., Genius J., Moessner R., Riederer P., Manji H.K., Grunze H., Rujescu D., Moeller H.-J., Lesch K.-P., Vescovi A.L. Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells. Neuropsychopharmacology 2010, 35:893-903.
7. Borrelli E., Nestler E.J., Allis C.D., Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60:961-974.
8. Bose S.K., Mehta M.A., Selvaraj S., Howes O.D., Hinz R., Rabiner E.A., Grasby P.M., Turkheimer F.E., Murthy V. Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain. Neuropsychopharmacology 2011, 36:2258-2265.
9. Casanova R., Srikanth R., Baer A., Laurienti P.J., Burdette J.H., Hayasaka S., Flowers L., Wood F., Maldjian J.A. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. NeuroImage 2007, 34:137-143.
10. Citri A., Malenka R.C. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 2008, 33:18-41.
11. Cowen D.S. Serotonin and neuronal growth factors - a convergence of signaling pathways. J. Neurochem. 2007, 101:1161-1171.
12. Cramer S.C., Sur M., Dobkin B.H., O'Brien C., Sanger T.D., Trojanowski J.Q., Rumsey J.M., Hicks R., Cameron J., Chen D., Chen W.G., Cohen L.G., deCharms C., Duffy C.J., Eden G.F., Fetz E.E., Filart R., Freund M., Grant S.J., Haber S., Kalivas P.W., Kolb B., Kramer A.F., Lynch M., Mayberg H.S., McQuillen P.S., Nitkin R., Pascual-Leone A., Reuter-Lorenz P., Schiff N., Sharma A., Shekim L., Stryker M., Sullivan E.V., Vinogradov S. Harnessing neuroplasticity for clinical applications. Brain 2011, 134:1591-1609.
13. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010, 33:424-434.
14. Draganski B., Gaser C., Busch V., Schuierer G., Bogdahn U., May A. Neuroplasticity: changes in grey matter induced by training. Nature 2004, 427:311-312.
15. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
16. Geuze E., Vermetten E., Bremner J.D. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry 2005, 10:160-184.
17. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999, 21:46S-51S.
18. Hahn A., Lanzenberger R., Wadsak W., Spindelegger C., Moser U., Mien L.-K., Mitterhauser M., Kasper S. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. J. Neurosci. 2010, 30:14482-14489.
19. 11C]way-100635. Brain Res. 1997, 745:96-108.
20. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 1096-1112.
21. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.-C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
22. Kanai R., Rees G. The structural basis of inter-individual differences in human behaviour and cognition. Nat. Rev. Neurosci. 2011, 12:231-242.
23. Kasper S., Tauscher J., Willeit M., Stamenkovic M., Neumeister A., Kufferle B., Barnas C., Stastny J., Praschak-Rieder N., Pezawas L., de Zwaan M., Quiner S., Pirker W., Asenbaum S., Podreka I., Brucke T. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder - implications for psychopharmacology. World J. Biol. Psychiatry 2002, 3:133-146.
24. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., Cole G.M., Satyamurthy N., Cummings J.L., Small G.W., Phelps M.E. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:702-707.
25. Klein A., Andersson J., Ardekani B.A., Ashburner J., Avants B., Chiang M.-C., Christensen G.E., Collins D.L., Gee J., Hellier P., Song J.H., Jenkinson M., Lepage C., Rueckert D., Thompson P., Vercauteren T., Woods R.P., Mann J.J., Parsey R.V. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. NeuroImage 2009, 46:786-802.
26. Kranz G.S., Hahn A., Savli M., Lanzenberger R. Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2000.
27. la Fougère C., Grant S., Kostikov A., Schirrmacher R., Gravel P., Schipper H.M., Reader A., Evans A., Thiel A. Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. NeuroImage 2011, 56:951-960.
28. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.-K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol. Psychiatry 2007, 61:1081-1089.
29. Lewis D.A., González-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33:141-165.
30. Mamo D., Graff A., Mizrahi R., Shammi C.M., Romeyer F., Kapur S. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am. J. Psychiatry 2007, 164:1411-1417.
31. May A. Experience-dependent structural plasticity in the adult human brain. Trends Cogn. Sci. 2011, 15:475-482.
32. McClung C.A., Nestler E.J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 2008, 33:3-17.
33. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999, 24:521-529.
34. Mogha A., Guariglia S., Debata P., Wen G., Banerjee P. Serotonin 1A receptor-mediated signaling through ERK and PKCa is essential for normal synaptogenesis in neonatal mouse hippocampus. Transl. Psychiatry 2012, 2.
35. Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 1992, 12:571-583.
36. Ogren S.O., Eriksson T.M., Elvander-Tottie E., D'Addario C., Ekström J.C., Svenningsson P., Meister B., Kehr J., Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behav. Brain Res. 2008, 195:54-77.
37. 1A receptor-regulated signal transduction pathways in brain. Cell. Signal. 2010, 22:1406-1412.
38. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
39. Puig M.V., Artigas F., Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb. Cortex 2005, 15:1-14.
40. Salvadore G., Nugent A.C., Lemaitre H., Luckenbaugh D.A., Tinsley R., Cannon D.M., Neumeister A., Zarate C.A., Drevets W.C. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. NeuroImage 2011, 54:2643-2651.
41. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
42. Savitz J.B., Drevets W.C. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009, 164:300-330.
43. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol. 2009, 88:17-31.
44. Spindelegger C., Lanzenberger R., Wadsak W., Mien L.K., Stein P., Mitterhauser M., Moser U., Holik A., Pezawas L., Kletter K., Kasper S. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Mol. Psychiatry 2009, 14:1040-1050.
45. 11C]WAY-100635. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2159-2168.
46. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 2006, 58:115-134.
47. Tost H., Braus D.F., Hakimi S., Ruf M., Vollmert C., Hohn F., Meyer-Lindenberg A. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat. Neurosci. 2010, 13:920-922.
48. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
49. Underwood M.D., Kassir S.A., Bakalian M.J., Galfalvy H., Mann J.J., Arango V. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int. J. Neuropsychopharmacol 2012, 15:435-447.
50. van Tol M.-J., van der Wee N.J.A., van den Heuvel O.A., Nielen M.M.A., Demenescu L.R., Aleman A., Renken R., van Buchem M.A., Zitman F.G., Veltman D.J. Regional brain volume in depression and anxiety disorders. Arch. Gen. Psychiatry 2010, 67:1002-1011.
51. Vetencourt J.F.M., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castrén E., Maffei L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320:385-388.
52. 11C]WAY-100635. Radiochim. Acta 2007, 95:1-6.
53. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 2001, 56:479-485.
54. Wilson C.C., Faber K.M., Haring J.H. Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: evidence for a glial mechanism. Brain Res. 1998, 782:235-239.
55. 18F]fallypride and voxel-based morphometry study. NeuroImage 2009, 46:31-38.
56. Yan W., Wilson C.C., Haring J.H. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res. Dev. Brain Res. 1997, 98:185-190.
57. Ye X., Carew T.J. Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins. Neuron 2010, 68:340-361.
58. Zatorre R.J., Fields R.D., Johansen-Berg H. Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat. Neurosci. 2012, 15:528-536.